Devika Das/LinkedIn
Apr 22, 2025, 09:40
Devika Das: The HER2 diagnostic and treatment landscape in NSCLC
Devika Das, Associate Professor of Medicine at the University of Florida College of Medicine, shared a post on LinkedIn:
“HER-2 testing in Non small cell lung cancer is often underrecognized and confusing.
Sharing brief thoughts on importance of testing along with our expert pathology colleague on this oncogene driven lung cancer which could be driving about 2-4% of all NSCLC diagnosed and is now targetable clinically!
Thank you, COR2ED, Rahul Gosain and Rohit Gosain for inviting us to have this nuanced discussion as it pertains to clinical utility and opportunities in this emerging space.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 11, 2025, 07:18
May 11, 2025, 07:13
May 11, 2025, 06:58
May 11, 2025, 06:45
May 10, 2025, 23:57